Sort   by:  
 Page size 
GenomicsDrug treatment of colorectal and endometrial cancer cell lines
We used expression profiling of colorectal cancer and endometrial cancer cell lines treated with demethylating agents to search for epigenetically regulated miRNAs. The study included three MMR-deficient colorectal cancer cell lines (HCT116, HCT15, and RKO), two MMR-proficient colorectal cancer cell...
ORGANISM(S): Homo sapiens 
2014-12-31 | GSE55930 | GEO
UnknownElevated MiR-222-3p promotes proliferation and invasion of endometrial carcinoma via targeting ERα.
Not available
S-EPMC3909214 | biostudies-literature
UnknownEndometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model.
Not available
S-EPMC5735020 | biostudies-literature
UnknownAdiponectin receptor 1 regulates endometrial receptivity via the adenosine monophosphate‑activated protein kinase/E‑cadherin pathway.
Not available
S-EPMC11350624 | biostudies-literature
UnknownEffects of Inhibitors of the Activity of the Circulating Renin-Angiotensin System on the Growth and Proliferation of Endometrial Cancer Cells.
Not available
S-EPMC12652496 | biostudies-literature
ProteomicsRole of prorenin receptor (P)RR in endometrial cancer cell growth
Endometrial cancer is the most commonly diagnosed gynecologic malignancy in women after breast, lung and colorectal cancer. Despite numerous scientific advances, the incidence and mortality rate of endometrial cancer is on the rise. Considerable research effort has therefore been placed on understan...
ORGANISM(S): Homo sapiens (Human) 
2022-04-23 | PXD023042 | Pride
Quantitative proteomics Endometrial epithelial cancer cell Cellular proliferation Tandem mass tags An3ca and hec-1a Atp6ap2 (p)rr Ishikawa Cellular viability 
UnknownThe allosteric AKT inhibitor, MK2206, decreases tumor growth and invasion in patient derived xenografts of endometrial cancer.
Not available
S-EPMC5718805 | biostudies-literature
UnknownIn-vitro and in-vivo combined effect of ARQ 092, an AKT inhibitor, with ARQ 087, a FGFR inhibitor.
Not available
S-EPMC5404396 | biostudies-literature
TranscriptomicsExpression profile of transcripts associated with Apcin-induced growth inhibition and apoptosis in endometrial carcinoma
Background: Endometrial carcinoma (EC) is a common gynecological malignancy with increasing incidence and death rate during the past years. In order to obtain better prognosis, it is necessary to develop novel therapy strategies for EC, especially for molecular targeted therapy. CDC20 is an Anaphase...
ORGANISM(S): Homo sapiens 
2024-06-30 | GSE167548 | GEO
UnknownMiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo.
Not available
S-EPMC3210504 | biostudies-literature
Sort   by:  
 Page size